What Changes? Pfizer Fudged Neurontin Studies
9 CommentsBy Ed Silverman // November 11th, 2009 // 6:31 pm
• Pharma Blog » Archives
Off Label Promotion
Sanofi-Aventis Whistleblower Claims Dismissed
Make a commentBy Ed Silverman // December 20th, 2008 // 9:08 am
Novartis Guards Against Unapproved Advertising
4 CommentsBy Ed Silverman // December 11th, 2008 // 6:34 am
Judge Says Whistleblower Suit Should Be Tossed
7 CommentsBy Ed Silverman // August 6th, 2008 // 8:27 am
FDA Fails To Pursue Off-Label Violations: Report
41 CommentsBy Ed Silverman // July 28th, 2008 // 1:00 pm
Judge Urges Lilly To Settle Zyprexa Lawsuits
5 CommentsBy Ed Silverman // July 4th, 2008 // 10:22 am
A Social Networking Site For Docs And Pharma
5 CommentsBy Ed Silverman // May 30th, 2008 // 8:25 am
FDA’s Off-Label Guidance: Fantasy Or Framework?
8 CommentsBy Ed Silverman // April 25th, 2008 // 12:20 pm
Pfizer On The Hook For Off-Label Generic Use
9 CommentsBy Ed Silverman // March 22nd, 2008 // 9:15 am